Dilaveris Polychronis, Pantazis Antonios, Giannopoulos Georgios, Synetos Andreas, Gialafos John, Stefanadis Christodoulos
A'University Department of Cardiology, Hippokration Hospital, Athens, Greece.
Europace. 2006 May;8(5):352-7. doi: 10.1093/europace/eul015.
Dyssynchrony imposed on ventricular function by right ventricular (RV) apical pacing may lead in some cases to worsening or appearance of heart failure (HF) symptoms. This is a result of an altered pattern of activation, leading to several histological and functional adjustments of the left ventricle, including inhomogeneous thickening of the ventricular myocardium and myofibrillar disarray, fibrosis, disturbances in ion-handling protein expression, myocardial perfusion defects, alterations in sympathetic tone and mitral regurgitation. Studies of mid- and long-term effects of RV apical pacing on left ventricular (LV) function have demonstrated a progressive decline in ejection fraction and other indices of LV functional competence. Upgrading RV pacing systems to biventricular resynchronization modalities is a theoretically promising option for paced patients with worsening HF. The potentially favourable effect of upgrading on LV functional indices and patient clinical status has been demonstrated in few, non-randomized trials. Apart from the scantiness of existing clinical data, issues concerning technical aspects of the procedure and selection of eligible patients are raised. Is pacing-induced dyssynchrony equivalent to the indigenous dyssynchrony in unpaced patients with HF? What selection criteria should be applied in order to identify potential responders to cardiac resynchronization therapy in this patient population? Answers to these and more questions are still lacking.
右心室心尖部起搏对心室功能造成的不同步在某些情况下可能导致心力衰竭(HF)症状恶化或出现。这是激活模式改变的结果,会导致左心室出现一些组织学和功能上的调整,包括心室心肌不均匀增厚、肌原纤维排列紊乱、纤维化、离子处理蛋白表达紊乱、心肌灌注缺陷、交感神经张力改变以及二尖瓣反流。关于右心室心尖部起搏对左心室(LV)功能的中长期影响的研究表明,射血分数和左心室功能能力的其他指标会逐渐下降。对于心力衰竭症状恶化的起搏患者,将右心室起搏系统升级为双心室再同步模式在理论上是一个有前景的选择。在少数非随机试验中已经证明了升级对左心室功能指标和患者临床状况的潜在有利影响。除了现有临床数据匮乏之外,还出现了有关该操作技术方面和符合条件患者选择的问题。起搏诱发的不同步与未起搏的心力衰竭患者的原发性不同步是否等效?为了在该患者群体中识别心脏再同步治疗的潜在反应者,应该应用哪些选择标准?这些以及更多问题的答案仍然缺失。